Sculponeatin N exhibits significant anti-inflammatory activity by inhibiting the production of nitric oxide (NO) in lipopolysaccharide (LPS)-stimulated microglial cells. This property makes it a potential candidate for research into neurodegenerative diseases where neuroinflammation plays a key role, such as Alzheimer's and Parkinson’s disease. It also shows moderate cytotoxic effects against certain cancer cell lines, suggesting possible utility in anticancer drug development. Due to its natural origin and bioactive profile, Sculponeatin N is primarily used in preclinical studies to explore new therapeutic pathways in inflammation and oncology.